Brian Philip

Company: Triumvira Immunologics Inc

Job title: Associate Director of Allogeneic Therapy


Making Solid Tumour Immunotherapy Safer and More Accessible 1:45 pm

TAC T-cell Antigen Coupler technology works directly with the T cell receptor to aid tumour recognition and targeting Closely mirroring the natural T cell response TAC technology offers key advantages including reduced risk of tonic signalling, reduced risk from cytokine release, and retention of memory phenotype on engineered cells TAC design offers potential for both…Read more

day: Day 2 - Track B - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.